Autoimmune Life Blog

In the early 1980s, the leadership team at Virginia Mason made the important decision to establish a biomedical research center focused on immunology. Immunology at that time was an emerging field, anticipating a future era of medical applications.

A new study recently reported in the New England Journal of Medicine demonstrates that consumption of a peanut-containing snack by infants who are at high-risk for developing peanut allergy prevents the subsequent development of allergy.

“What she’s done for medical science, the arts and education is outright phenomenal,” says Tom Wight, PhD, Director of Benaroya Research Institute’s Matrix Biology Program. He’s talking about his grade school friend Ann Ramsay-Jenkins.

Originally from Auburn, Wash., Kerri Arceo moved to Guam where she met her husband, a native of the island territory. For years she enjoyed a fulfilling life teaching religion at the St. John’s Episcopal School.

In clinical trials, not all individuals respond in the same way to particular immunological therapies.

Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.

Scientists at BRI recently received a $2.2 million grant from the National Institutes of Health to find a unique biomarker that initiates and drives allergies.

A labor of love to honor a much loved man provides funds for type 1 diabetes research at Benaroya Research Institute at Virginia Mason (BRI). The annual David J. Fanning Memorial Golf Tournament has raised nearly $200,000 since its inception in 2011.

BRI Associate Investigator Adam Lacy-Hulbert, PhD, and his team of researchers, including Affiliate Investigator Lynda Stuart, MD, PhD, recently joined BRI. They bring new expertise in Inflamatory Bowel Disease (IBD) and the basic functioning of the immune system. Dr.

Researchers at BRI have used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA).